# Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy

> **NCT05426668** · — · RECRUITING · sponsor: **Karsten Gavenis** · enrollment: 170 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05426668
- **Lead sponsor:** Karsten Gavenis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-24
- **Primary completion:** 2027-11
- **Final completion:** 2028-02
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2026-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05426668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05426668, "Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT05426668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*